Gene Therapy for Friedreich Ataxia Cardiomyopathy Shows Promise in Early Trial A phase 1/2 clinical trial evaluating an intravenous adeno-associated viral gene therapy for Friedreich ataxia (FA) cardiomyopathy found the …
Tag: